# Deferasirox

NDC: 46708-325
Generic name: Deferasirox
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FOR SUSPENSION
Routes: ORAL
Marketing started: 20191121

FDA application: ANDA210060

## Active ingredients

- DEFERASIROX: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-325"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-325
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c8b84f3-6887-4485-b5e0-03f254b88a15